Psychogenic Movement Disorders by Carlo Dallocchio
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
20 
Psychogenic Movement Disorders 
 Carlo Dallocchio 
Department of Medical Specialities, Division of Neurology, Ospedale Civile 
Voghera (Pavia) 
Italy 
1. Introduction  
Abnormal movements and postures resulting from primary psychiatric disease are a 
diagnostic dilemma because all types of movement disorders may be mimicked by a 
psychogenic disease, including akinetic-rigid and hyperkinetic disorders, with the latter 
more frequent, particularly tremor, myoclonus, and dystonia (Williams et al., 2005; Reich, 
2006).  
Psychogenic movement disorders (PMDs), are a valuable model for all medically 
unexplained symptoms and raise arduous challenges for diagnosis and treatment indicating 
our restricted understanding of the true pathogenesis that causes them.  A multiplicity of 
terms such as “hysterical conversion”, “functional”, “psychosomatic”, “neuropsychiatric”, 
“dissociative motor disorders”,and so on, have been applied to describe neurological 
symptoms that cannot be attribute to any known organic disease (Mace & Trimble, 1991; 
Lang, 2006). The term “psychogenic” is the commonest in the movement disorder literature, 
but there is no unanimity whether it reflects the precise nature of a syndrome containing 
both neurologic and psychiatric components. 
By the late-19th century, psychoanalytic theory ruled medical reasoning about these 
symptoms. Originally referring to these disorders as hysteria, neuropsychiatrists began 
illustrating the various clinical phenomenological aspects of such disorders. Paralysis, 
tremors, convulsions and sensory alterations were identified as sometimes being due to 
hysteria. Subsequently, different etiologies of dystonia, tremor, myoclonus and other 
movement disorders were recognized. Over the years, newer clinical criteria, laboratory 
investigations, particularly neurophysiological findings, and improved neuroimaging have 
provided significant insights about the psychogenicity of the diagnosis. However, a 
misdiagnosis is possible either on patients originally believed to have a conversion disorder 
or because PMD was never considered on differential diagnosis (Rosebush & Mazurek, 
2006; Lang & Gupta, 2009).  
The pathophysiology of PMDs are not yet well known, but functional brain imaging studies 
combined with other neurophysiologic techniques are starting to help understand them 
(Stone & Carson, 2011). These studies promise an understanding of these symptoms in 
parallel neurologic and psychiatric ways. 
The diagnosis of a psychogenic movement disorder is often difficult and the level of 
diagnostics that the clinician has for PMD varies remarkably, depending on the clinical 
feature of the movement disorders and the accompanying signs and symptoms. PMDs are 
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classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) of the 
American Psychiatric Association as conversion disorder of motor subtype and must be 
differentiated from factitious disorder and malingering, in which the abnormal movements 
are purposefully forged. Since most patients with conversion symptoms are found to have 
“no psychiatric disease” by the psychiatric and “no neurologic disease” by the neurologist, a 
multidisciplinary treatment approach, including the movement disorders neurologist, the 
consulting psychiatrist, and frequently a physical therapist, is crucial in obtaining symptom 
remission in many subjects (Williams et al., 2005; Stone et al., 2010).  
Although evidence for treatment of PMDs are lacking and is mainly based on case control, 
retrospective, or case report studies, the therapeutic process starts with the diagnosis and 
the explanation of the symptoms to the patient. To date, the treatment for each patient with 
PMDs is individualized and may include psychotherapeutic interventions, behavioral 
therapy, hypnosis, pharmachotherapy, physical therapy, and other approach. 
Physicians should not underestimate the importance of distress and disability that subjects 
with these symptoms suffer. Failure to diagnose a PMDs inevitably delays treatment and 
may perpetuate a patient’s situation of disability (Williams et al., 2005). In addiction, 
patients with somatisation had approximately twice the medical care utilisation and twice 
the annual medical care costs of non-somatizing patients and spend 1.3 to 3.9 days in bed 
per month compared to an average of one day or less for patients with major medical 
problems (Smith et al., 1986; Barsky et al., 2005). The current chapter reviews empirical 
evidence concerning clinical manifestations of PMDs and summarizes  how PMDs are 
currently diagnosed, investigated and treated. 
2. Epidemiology and risk factors 
Although psychogenic neurological symptoms are common and account for 1–9% of 
neurological symptoms observed in the general population (Lempert et al., 1990; Factor et 
al., 1995), the following caveats should be borne in mind: (i) available reports result from 
tertiary movement disorders centers, and therefore it is difficult to valuate how common 
these disorders are in the general population or even what is the prevalence respect to all 
conversion disorders, (ii) the insufficiency of confirmatory diagnostic testing prejudices case 
definition even when clinical satisfactory criteria are applied and (iii) several clinical settings 
and situations (e.g., neurology or psychiatry in- or outpatient service, emergency room or 
general practitioner cases, chronic or refractory cases, etc.) may confound case ascertainment 
(Lang, 2006).  In the only series dividing medically unexplained motor symptoms into 
“absence of motor function” and “presence of abnormal motor activity”, 48% of the patients 
had index symptoms in the former category, while 52% had symptoms, such as tremor, 
dystonia or ataxia (Crimlisk et al., 1998).  
PMDs also can occur over a wide range of ages from teenage to the mid seventies (Deuschl 
et al.,1998; Feinstein et al., 2001). The mean age at onset described in several case series on 
these disorders ranges between 37 years and 50 years and women are predominantly 
affected with a range of 61–87% (Hinson et al., 2005; Factor et al., 1995).  
There are no data on racial distribution in the published research, however a trans-cultural 
comparison between patients with these disorders in the USA, in Spain, and in Brazil 
showed essentially similar demographic and clinical characteristics by ethnic origin (Cubo et 
al., 2005; Munhoz et al., 2010). Nearly 15% of patients with a psychogenic movement 
disorder have also an underlying organic movement disorder (Ranawaya el al., 1990). 
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Curiously, PMDs are frequently seen in subjects employed in health care professions or 
allied health care professionals possibly due to the exposure to disease  and those who have 
witnessed the organic form of the movement disorder (e.g. Parkinson’s disease) in other 
relatives (Miyasaki et al., 2003; ) 
More frequently, PMDs are encountered in the context of a second coexisting psychiatric 
illness. Feinstein and colleagues followed 88 patients suffering from psychogenic movement 
disorders, over an average of 3 years. 42 patients agreed to undergo a structured psychiatric 
interview. The most common life time prevalence rates were found for depression (42%), 
anxiety disorders (62%), a combination of depression and anxiety (29%) and conversion 
disorder (95%). Personality disorder (antisocial, borderline, dependent, avoidant or a 
mixture of those) was diagnosed in 42% of patients tested (Feinstein et al., 2001). Among the 
a series of 127 patients with psychogenic tremor, depression (51%) and anxiety (31%) were 
the most common psychiatric co-morbidities (Jankovic & Thomas, 2006). 
Risk factors for these disorders include: history of sexual abuse or rape, physical trauma, 
previous surgery, major stressful life experiences (Williams et al., 2005; Feinstein et al., 
2001). Many patients with functional neurologic symptoms report just as much physical 
disability and are more distressed than patients with neurologic disease. Furthermore, 
subjects with these symptoms are more likely to be out of work because of ill health than the 
general population (Stone et al., 2011). 
3. Pathophysiology  
In reviewing the history of psychogenic neurologic disorders, hysterical paralisis and 
sensory loss have been known presumably back in antiquity (Ng BY, 1999) and have been 
debated before the late 19th century, when Charcot, Janet, Breuer, and Freud gave a 
systematic psychological account of these phenomena. (Charcot, 1889; Janet, 1907; Freud, 
1910). From then on, there has been a large body of literature regarding the possible 
psychogenic, psychoanalytical, cultural and biological mechanisms underlying PMDs.  
According to Janet, traumatic events can cause a functional separation (dissociation) of 
structures of memory, identity, insight, and perception of the environment from conscious 
awareness. As a result, unexplained symptoms emerge from the activation of these 
dissociated structures (Janet, 1889). Patients suffering from non-organic motor symptoms 
are singularly susceptible to hypnosis, an inducible state of dissociation.  
This theory was later developed by Breuer and Freud, who considered dissociation a 
psychological defence mechanism rather than a disorganizing phenomenon: the mental 
conflict is partially or completely resolved by the expression of physical symptoms, which is 
called primary gain. According to this psychodynamic model, dissociation preserves the 
subject from the invalidating affect associated with remembrances of trauma by its 
“conversion” in to somatic symptoms and once these latter have developed, may confer 
further advantages to the patient (attention, solicitude, social interaction, etc.) or “secondary 
gains”(Breuer & Freud, 1895).  
In contemporary psychiatry, dissociative symptoms and dissociation as a mechanism are 
taken to point to a role traumatic events in pathogenesis. Various factors may provide to the 
pathway to conversion disorder, perhaps comprehending, concurrent somatic illness in 
adolescence or adulthood, parental illness in the subject childhood, and early illness. In 
particular physical or sexual abuse in childhood have considered key factors in the 
generation of vulnerability to unexplained somatic symptoms (Ovsiew, 2006). 
www.intechopen.com
 
Psychiatric Disorders – Trends and Developments 
 
496 
The definite nature of emotional disorders responsible of psychogenic disorders, and their 
functional consequences on neural systems in the brain, still remain largely unknown.  
In the closing decades of the 19th century, researchers have progressively been looking for 
organic correlates of PMDs and the neural mechanism perspective became more approved 
with the advent of novel functional neuroimaging methods. These new approaches have 
now allowed to detect in vivo regionally specific changes in cerebral blood flow and task-
related changes in the attempt to identify specific neural correlates associated with 
conversion symptoms, that is the “dynamic lesion“ that Charcot considered responsible for 
the neurological signs he observed in patients affected by “hysteric movement disorders”. 
PMDs evoke notable interest because, as protean disorders of willed action or intention, the 
underlying mechanism are supposed to be the result of unconscious processes, a sort of 
impairment to the volition system, once any demonstrative organic or feigning dysfunctions 
has been excluded (Fink, 2006). Psychogenic movements may be voluntary or involuntary. 
Factitious disorder and malingering describe when the disorder is voluntary, and the 
patients are lying. On the other hand, most patients with PMDs have a conversion aetiology 
and manifest movements that look voluntary, even if patients declare that the movements 
are involuntary. By a physiological point of view we can not tell the difference between 
voluntary and involuntary, but we know (most of time) that both are preceded by a normal 
“readiness potential” or so called Bereitschaftspotential, a manifestation of cortical 
contribution to the pre-motor planning of volitional movement (Shibasaki & Hallet, 2006) 
and share cortical structures that are involved in movement planning and execution.   
In a go-nogo task, while a patient underwent functional magnetic resonance imaging 
(fMRI), Cojan et al. demonstrated that distinct inhibitory mechanism are implicated in 
simulation and conversion disorders and that conversion symptoms do not act through 
cognitive inhibitory circuits, but involve selective activations in midline brain regions 
associated with self-related representations and emotion regulation  (Cojan, 2009). Other 
neuroimaging results have shown increase activation in limbic regions, such as orbitofrontal 
or cingulated cortex during conversion symptoms affecting different motor or sensory  
modalities (Vuilleumier, 2005, Nowak, 2009). A recent single photon emission computed 
tomography (SPECT) study by Czarnecki et al. suggested that the prominent hypoperfusion 
of the prefrontal and anterior cingulate cortex in patients with psychogenic tremor likely 
indicates deactivation of the anterior portion of the default mode network (the baseline state 
of the brain that deactivates during goal-directed activity), which could prove to be a 
peculiar marker of PMDs. Moreover, this study reported resting hyperperfusion in left 
insula and left inferior frontal gyrus in psychogenic tremor that may also prove to be a 
disease characteristic (Czarnecki et al. 2011). 
Voon and colleagues used functional magnetic resonance imaging (fMRI) to study patients 
with psychogenic tremor who could voluntarily mimic their tremor and showed 
hypoperfusion of the right temporal parietal junction only during involuntary movements. 
The authors speculate that this hypoactivity may reflect the lack of an appropriate sensory 
prediction signal, being the right temporal parietal junction implicated as a general 
comparator of internal predictions with actual events. This suggests a loss of self-agency o 
awareness that made the movements feel involuntary (Voon et al., 2010).  
There may be a pathologic unconscious influence on movement production associated with 
a disconnection between movement production and sense of volition (Hallet, 2010). Besides, 
earliest affective or stress-related factors, neuropsychological and psychosocial processes, 
perhaps involved primitive reflexive mechanisms of protection and alertness that are not 
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fully independent of conscious control (Vuilleumier, 2005). This prominent evidence in 
favour of multi causes of PMDs requires a multifaceted approach integrating innovative 
neuroimaging and neurophysiological techniques with social, psychological and 
psychodynamic theories. 
4. Clinical manifestations and diagnostic clues 
The diagnosis of PMDs remains a fascinating and challenging dilemma in both clinical 
neurology and psychiatry. It should not be considered as a diagnosis of exclusion but 
should be established on positive clinical criteria to determine whether abnormal 
movements are produced by organic disease, psychiatric disorder, or both (Jankovic & 
Thomas,  2006). Taking into account that unnecessary investigations should be prevented, 
more notable evidence is required before a diagnosis of psychogenic disorder can be 
confirmed. Some studies, including exhaustive neurologic assessments and modern 
diagnostic techniques, have shown that a misdiagnosis is possible on long-term follow-up of 
patients initially diagnosed with a conversion disorder and later identified as having an 
organic disorder (Moene et al., 2000; Lang, 2006; Lang & Gupta, 2009). Otherwise, failure to 
make the diagnosis arises because PMDs were seldom contemplated in the differential 
diagnosis, especially in patients who have a coexistent neurologic disease, such as 
neurodegenerative or demyelinating disorder or epilepsy. Coexistent organic neurologic 
disease was present in 37% of patients with psychogenic tremor followed for over 3 years 
(Jankovic et al., 2004). Additionally, the problem is exacerbated by a tendency among 
physicians to be concerned about missing an “organic” diagnosis in order to relieve the 
patient from a “functional” one, even if the latter is treatable and the former is not 
(Rosebush & Mazurek, 2006). Another troubling side of these disorders is the reluctance of 
many physicians to put their judgments and conclusions into a transparent discussion with 
the patient. So an ambivalent communication wanes to deliver the presumed diagnosis in 
real terms and running the risk that patients continue to explore for months or years further  
opinion through “doctor shopping”. (Friedman & LaFrance WC, 2010). 
Because many patients or family members of patients with PMDs are strongly reluctant to 
the diagnosis not explained organically and may resistant to a psychiatric referral, a 
multidisciplinary approach, including the general or movement disorders neurologist and 
the consulting psychiatrist is essential. The role of the neurologist is primary in determining 
whether there is an underline neurologic disorder and whether it could explain the clinical 
picture. Hardly mental health professionals undertake a treatment of such patients without 
the neurologic diagnosis has been either established  or dismissed (Feinstein et al., 2001; 
Williams et al., 2005). 
Fahn and Williams developed four degrees of certainty for the diagnosis (Tab. 1) of 
psychogenic dystonia, which are commonly applied in clinical practice and research to all 
PMDs (Fahn & Williams, 1988). Shill and Gerber formulated further criteria with a 
denomination of “clinically proven PMDs” which requires remission when the patient is 
unobserved or with psychotherapy or when there is a Bereitschaftspotential on 
electroencephalography (for myoclonus only). Moreover, they added further criteria of 
PMDs to include excessive pain or fatigue and previous disease exposure (Shill & Gerber, 
2006). Developing this idea, Hallett proposed that a new designation of “laboratory proven 
PMDs” could be considered (Peckham & Hallett, 2009). A recent study demonstrated that 
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the finger tapping test may provide an objective tool to aid the clinical diagnostic criteria set 
by Fahn and Williams for identifying patients with PMDs (Criswell et al., 2010). 
 
Documented psychogenic 
Movements are persistently relieved by psychotherapy or psychological suggestion or 
with the administration of placebos. If the patient is observed to be symptom free 
when left alone, this may also be documented as psychogenic; however, this feature is 
usually indicative of malingering or factitious disorder. 
Clinically Established Psychogenic 
Inconsistent or incongruent with classical dystonia (on examination, the patient is 
unable to move the limbs but is able to dress herself in daily life). In addition, one or 
all of the following is highly suggestive: other neurologic signs present that are 
psychogenic (self-inflicted injuries, false weakness, false sensory findings), an obvious 
psychiatric disturbance is present, and multiple somatizations are present. 
Probable Psychogenic 
Movements are inconsistent or incongruent, but there are no other features (as above) 
to further support the diagnosis. Movements are consistent with organic dystonia, but 
there are other features on examination to suggest psychogenicity (self-inflicted 
injuries, false weakness, false sensory findings). Multiple somatizations are present, 
but movements are consistent with organic dystonia. 
Possible Psychogenic 
An obvious emotional disturbance is present, but movements are consistent with 
organic dystonia. 
Table 1. The classification of psychogenic movement disorders (Williams & Fahn, 1995) 
An additional support, that seems appropriate to capture the complexity of PMDs and that 
can be used to assess PMDs and test the efficacy of intervention strategies is the Psychogenic 
Movement Disorder Rating Scale (PMDRS). This clinimetric assessment describes and 
quantifies the complicated phenomenology of PMDs, and provides the following six types 
of information: movement phenomenology, anatomic distribution and severity of abnormal 
movements, duration of abnormal movements, assessment of two functions (gait and 
speech), impairment-based incapacitation by abnormal movement or function, and total 
severity score (Hinson et al., 2005).  
It should be emphasized that observation and examination are the most important tools for 
the physician looking for inconsistency of movements. The first trace of psychogenicity in a 
patient presenting with such abnormal motor activity can be obtained by history (Table 
2.A). This may comprise psychiatric history, childhood history, personality factors, drug 
experience, recent personal and family life events, stressful situations or work-related  
injury, litigation or compensation pending, personal encounter or knowledge of similar 
disorders serving as a “model” and possible secondary gain (Bhatia & Schneider, 2007; 
Nowak & Fink, 2009).  
In general, the manner of onset characterizes the clinical presentation of PMDs (Table 2.B): 
symptoms appear abruptly, frequently in the context of precipitating factors and, the 
highest disability and severity are reached quickly (Feinstein et al., 2001). Important 
specifics of PMDs are an inconsistent character of movement (unusual presentation in 
amplitude, frequency, distribution), and they may increase with attention or decrease with 
distraction (Miyasaki, 2003). A deliberate slowness of movement is incongruent with an 
www.intechopen.com
 
Psychogenic Movement Disorders 
 
499 
organic movement disorders, as well as simultaneous occurrence of variegated abnormal 
movements and disfunctions, and peculiarly, patients may seem to struggle and put in more 
effort than needed to complete the task (Hinson & Blacke Haren 2006; Bhatia & Schneider 
2007).  Often, this is manifest by sighing, grimacing, and using their whole body to do a 
movement. The movements themselves may appear bizarre and should be incongruous 
with a known movement disorder.  
There are controversial points of view whether there is a place for placebo in management 
of PMDs, as it reflects ethical evaluations and can infringe the relationship between 
physician and patient. Although a response to placebo of a movement disorder is seriously 
supportive of a diagnosis of PMDs (Espay et al., 2009). Equally, spontaneous resolution and 
improvement of unexplained symptoms with psychiatric evaluation or psychotherapy are 
highly suggestive of psychogenic aetiology of them (Fahn, 1994). 
Diagnostic testing should be used primarily to give further support to the underlying 
clinical suspicion that it is psychogenic. Routine blood test including haematology, thyroid 
function, renal and liver function, and evaluation for Wilson’s disease may be helpful. 
Magnetic resonance imaging can be helpful for excluding an underlying structural, vascular 
or demyelinating lesion, particularly if the abnormal movement is unilateral or 
asymmetrical. Neurophysiology studies to evaluate tremor and myoclonus can aid in the 
diagnosis of PMDs. Dopamine transporter (DAT) SPECT and Fluorodopa (18F-dopa) PET 
scans have been proven quite helpful in distinguishing psychogenic parkinsonism from 
Parkinson’s disease or essential tremor (Kagi et al., 2010; Czarnecki et al. 2011). 
The role of the consulting psychiatrist is to interpret the psychopathology present, ascertain 
its relevance to the presenting PMDs symptoms and establish a positive rapport with the 
patient. If this appears feasible, the psychiatrist will then begin the treatment course, with 
adequate collaborative support from neurologist (Williams et al., 2005).  
However,  psychiatric aspects and categorical differentiations, which are discussed in detail 
elsewhere in this book, also apply to PMDs. In brief, the psychiatric examination includes 
research of individual psychodynamics and significant environmental events as well as a 
complete multiaxial delineation of specific psychopathology according to the official 
psychiatric classification system such as the Diagnostic and Statistical Manual of Mental 
Disorders, fourth Edition (DSM-IV). The primary psychopathology underlying PMDs can be 
divided into two categoric diagnostic subgroups: somatoform disorders on the one hand, 
and factitious disorders and malingering on the other. The first category includes 
conversion disorder and somatization disorder. Conversion disorder is likely the most 
common mechanism of PMDs and is defined by the DSM-IV criteria as a disorder including 
one or more symptoms, that are not the result of a neurological disorder, affecting voluntary 
motor or sensory function that suggest a medical condition and is associated with 
psychological factors. 
The primary psychiatric diagnosis varies: most cases are considered to be conversion 
disorders, in which the problem is generated by an unconscious mechanism, but 
infrequently some are factitious disorders or malingering, in which the abnormal 
movements are purposefully forged. Factitious disorders include intentional production of 
physical or psychological symptoms, where the goal is to assume the role of a patient and 
external incentives, such as economic gain or avoiding legal responsibility, are absent. In 
malingering, the symptoms can also be physical or psychological, but the individual is 
consciously aware of external pragmatic incentives, such as gaining financial compensation, 
acquiring drugs, avoiding work or school, et cetera, and when the external incentives are 
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removed, the symptoms resolve. Beyond a categorical diagnostic classification, it is often 
very intricate, especially initially, to face with a patient having PMDs and make a 
differential diagnosis among somatoform disorders, factious disorders, and malingering. 
Simplification may arise however, in the course further and exhaustive evaluation, by 
reinforcing the agreement between physician and patient and ensuring patient’s confidence 
in the treatment plan (Williams et al.,2006). Moreover, most patients with PMDs have a 
coexisting  variety of different psychiatric disturbances such as dysthymia, major 
depression, anxiety, adjustment disorders, obsessive-compulsive disorder, panic attacks, 
bipolar disorders and others (Williams et al., 2005; Bhatia & Schneider, 2007). Yet, it is 
important to add that many organic movement disorders have an important incidence of the 
above-named psychiatric diagnoses (Reich, 2006). Finally, the common occurrence of 
movement disorders complicating primary mental illness and their treatment makes it 
important for psychiatrists to be able to recognize the various movement disorders, some of 
which have singular phenomenology such as tardive akathisia, tardive dystonia, tourettism 
and some unusual form of parkinsonism or tremor (Factor et al., 2005). 
 
A) Historical 
1. Abrupt onset 
2. Static course 
3. Spontaneous remission 
4. Precipitated by minor trauma 
5. Obvious psychiatric disturbance 
6. Multiple somatization 
7. Employed in health profession 
8. Pending litigation or compensation 
9. Presence of secondary gain 
10. Young age (female>male) Inconsistent character of movement 
(amplitude, frequency, distribution, selective ability) 
B) Clinical 
1. Paroxysmal movement disorder 
2. Movements increase with attention or decrease with distrction 
3. Ability to trigger or relieve the abnormal movements with unusual or 
non physiological interventions (e.g.trigger points on the body, tuning 
fork) 
4. False weakness 
5. False sensory complaints 
6. Self-inflected injuries 
7. Deliberate slowness of movements 
8. Functional disability out of proportion to exam findings 
9. Movement abnormality that is bizarre, multiple or difficult to 
classifyUnresponsive to appropriate medications 
C) Therapeutic responses 
1. Response to placebos 
2. Unresponsive to appropriate medication 
3. Remission with psychotherapy 
Table 2. General clues suggesting that a movement disorder may be psychogenic (Miyasaki 
et al., 2003; Lang, 2006) 
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4.1 Types of psychogenic movement disorders 
4.1.1 Psychogenic tremor  
Although many patients has a mixture of different movement disorders, psychogenic 
tremor is the prevalent movement disorder, up to 55%, of all PMDs. Clinical sites affected 
include the hand (84%), the leg (28%), and generalized body tremor 20% (Thomas & 
Jankovic  2004).  Clinically, absence of finger tremor can be a positive diagnostic sign for 
psychogenic tremor (Jankovic & Thomas,  2006; Bhatia & Schneider, 2007) and attempting to 
immobilize the affected limb often makes a functional tremor worse, as well as loading the 
limb with weights tends to make the tremor worse, whereas organic tremor usually 
improves with this operation.  
The diagnosis may be supported by the  “coactivation sign”. As in the testing procedure for 
rigidity, the physician feels the increased muscle tone in the tremulous extremity in both 
directions and this cogwheel-like resistance is strictly related to tremor or if the patient can 
be made to relax completely (Deuschl et al. 1998). The technique of back-averaging 
electroencephalographic activity preceding the electromyographic  ones, can be useful to 
detect premovement  potential in subjects with psychogenic tremor, absent in organic 
involuntary movement (Brown & Thompson, 2001). Zeuner et al. using accelerometry to 
measure frequency changes during tapping showed that in contrast to parkinsonian and 
essential tremor, patients with psychogenic tremor revealed larger tremor frequency 
changes and marked variability in tapping (Zeuner et al., 2003). Entrainment of tremulous 
movements of different body parts into a single rhythm has been used clinically as a means 
of distinguishing these tremor forms. If functional tremor involves more than one limb, it 
usually has the same frequency. On the other hand, organic tremor usually has slightly 
different frequencies in different body parts. A quantified electrophysiological entrainment 
test performed on accelerometer or surface EMG tremor signals may provide supportive 
evidence of a functional tremor (McAuley & Rothwell 2004). Recently, Czarnecki and 
colleagues revealed distinct patterns  of cerebral perfusion, during rest and motor task, as 
measured by SPECT that distinguish psychogenic tremor from essential tremor and controls 
(Czarnecki et al. 2011). 
4.1.2 Psychogenic dystonia 
Dystonia exemplifies one of the longest history of misdiagnosis: for many centuries it was 
considered a psychogenic condition, then, after torsion dystonia was accepted as an organic 
entity in the early-20th century and different aetiologies of this condition were recognized, it 
was thought that psychogenic dystonia rarely occurred (Fahn, 2006). In general, 
psychogenic dystonia represents only approximately 5% of subjects with dystonia, but in 
most centers, it is the second most commonly encountered among PMDs  and accounts for 
20% to 50% of cases (Miyasaki et al., 2003). Psychogenic dystonia, classified as a secondary 
dystonia, largely remains a clinical diagnosis and there are no physiologic tests available 
that distinguish a psychogenic aetiology from an organic form (Peckham & Hallett, 2009). 
Psychogenic dystonia may not occur with the typical variability and distractibility of other 
PMDs and presents with fixed dystonic postures (Fig. 1) without return to the neutral 
position at rest from the beginning. Leg involvement is uncommon in adult-onset organic 
dystonia, as well as lack sensory tricks or relief by certain inexplicable trick action, and 
presence of severe pain suggest psychogenic dystonia, even if not in a specific way (Schrag, 
2006).  
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Controversial patients are those with dystonia developing within ours or days  after a minor 
injury, with a fixed distonic posture and severe pain. This kind of dystonia may be 
associated with features of complex regional pain syndrome type I. A study by Schrag and 
co-workers show that a substantial proportion of patients with fixed dystonia clearly fulfils 
criteria for a psychogenic dystonia (37%) or somatization disorder (29%). Although fixed 
dystonia sometimes developed in patients in whom a diagnosis of somatization disorder 
had already been made, a history of somatization was often unrecognized and, in many 
cases, only became evident after examination of primary care records (Schrag et al., 2004; 
Miyasaki et al., 2003). Various features of complex regional pain syndrome-related fixed 
dystonia suggest abnormal regulation of inhibitory interneuronal mechanisms at the 
brainstem or spinal cord level and impairment central synaptic reorganisation due to an 
interaction between neuroplastic activities and anomalous environmental necessities (Munts 
& Koehler, 2010). 
 
 
Fig. 1. A fixed dystonic posture of psychogenic origin 
4.1.3 Psychogenic parkinsonism 
Psychogenic parkinsonism is a rare syndrome accounting for 0.17–0.5% of all parkinsonism 
cases and representing nearly 10% of PMDs (Factor et al., 1995; Benaderette et al., 2006). In 
this disorder, atypical tremor occurs in  conjunction with extremely slow movements that 
are often accompanied by grimacing, sighing, or whole-body movements when patients do 
a simple motor task. Common characteristics of organic parkinsonism, such as hypomimia, 
decreased blink rate, axial rigidity, and ‘‘cogwheel’’ phenomenon are usually absent in 
psychogenic parkinsonism. On postural stability testing, patients may have bizarre 
responses including flailing of the arms and reeling backward without falling (Thomas & 
Jankovic, 2004). Additionally, patients with psychogenic parkinsonism may also suffer from 
depression, which can cause psychomotor retardation, a clinical condition which may be 
difficult to distinguish from the bradyphrenia associated to Parkinson’s disease (Morgan & 
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Sethi, 2006). It should be also remarked that parkinsonism or akinetic-rigid syndrome not 
uncommonly occur in the setting of major psychiatric disease and exposure to 
pharmacological agents. 
Electrophysiology studies can be supportive in distinguishing a Parkinson’s psychogenic 
tremor from other forms of tremor. Functional neuroimaging can be helpful in confirming a 
diagnosis of psychogenic parkinsonism. Loss of dopamine nerve function seen in organic 
parkinsonism can be measured by decreases in dopamine transporter density or presynaptic 
dopamine deficiency (I 123 B-CIT) on single positron emission computed tomography 
(SPECT) and Fluorodopa positron emission tomography (F-DOPA-PET). In psychogenic 
parkinsonism, these features are absent, but keeping in mind that other conditions, i.e. drug 
induced parkinsonism, dopa responsive dystonia-parkinsonism, have normal SPECT or F-
DOPA-PET scans (Benaderette et al., 2006; Scherfler et al., 2006).  
Table 3 summarizes the differences of clinical findings in Psychogenic parkinsonism, Drug-   
induced parkinsonism and Parkinson Disease.  
 
 Psychogenic 
Parkinsonism 
Drug-Induced 
Parkinsonism 
Parkinson Disease 
Onset Abrupt, varied age of 
onset 
Bilateral and 
symmetric, more 
common in the 
elderly 
Gradual,unilateral or 
asymmetric, typically 
in the 6th or 7th decade 
Cours Usually static with 
maximum disability 
early, condition may 
abruptly or gradually 
remit 
 
Acute or subacute Insidious, slowly 
progressive 
Tremor type Unilateral or bilateral, 
rest, postural, action; 
usually involving the 
dominant hand, 
varying frequency and 
amplitude, spreads 
when immobilizing 
the affected limb 
 
Not always present, 
bilateral, symmetric, 
postural or rest 
Unilateral or 
asymmetric at rest, 4-6 
Hz, worsens with 
distraction 
Bradykinesia Extremely slow 
movement often with 
fatigue, arrest or 
decrement; grimacing, 
sighing or whole body 
movements when 
performing simple 
task; normal speed of 
movements when not 
being examined 
Often the earliest and 
commonest 
manifestation,  facial 
hypomimia 
Slowing of rapid 
repetitive movements 
without fatigue, arrest 
or decrement 
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Rigidity Cogwheel absent, 
voluntary 
resistance which may 
decrease with 
distraction 
 
Often uniform, 
inconstant cogwheel 
rigidity 
Cogwheel rigidity 
Postural 
instability 
Impaired early, may 
have exaggerated or 
bizarre response to 
minimal backwards 
 
Mild stooping, 
decreased arm swing 
Impaired in moderate 
to advanced disease, 
retropulsion on pull 
test 
Speech Stuttering, bizarre 
dysarthria, distractible 
Mild stuttering Hypophonic, 
stuttering, 
tachyphemia 
Motor 
fluctuation 
Very rare complaint of 
“extra movements” on 
levodopa, no 
dyskinesias after long-
term levodopa 
treatment 
 
Absent Dyskinesias in half of 
patients on levodopa 
after 5-7 years, on-off 
fluctuations 
Psychiatric 
history 
Previous conversion 
disorders, 
somatisation, factious 
disorder, anxiety, and 
depression 
 
Relevant, particularly 
schizophrenia but 
also depression 
Depression may 
precede diagnosis 
Medication 
response 
Usually unresponsive 
to multiple medical 
trials 
Responds well to 
anticolinergic drugs, 
remittance within 
weeks or months 
when withdrawal of 
offending drug 
 
Responds well to 
levodopa and 
dopamine agonist 
Nonmotor 
problems 
Sexual dysfunction 
and sleep disturbances 
occur 
Possible swallowing 
less than normal, 
hallucination, rare 
costipation 
Dysautonomia, 
constipation, sexual 
dysfunction, sleep 
problem, hallucination 
Table 3. Clinical features of Psychogenic parkinsonism, Drug-induced parkinsonism and 
Parkinson Disease. Adapted from Morgan & Sethi, 2006. 
4.1.4 Psychogenic gait 
Abnormal gaits frequently occur in the setting of major psychiatric disease and represent 8% 
to 10% of all PMDs (Sudarsky, 2006). Psychogenic gate disorders are characterized by 
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exaggerated effort or fatigue with grimaces, excessive slowness, convulsive shaking, often 
with knee buckling especially when the patient has unilateral functional weakness, astasia-
abasia, arms are outstretched like a tightrope walker (Fig. 2), unusual uneconomic posture 
and bizarre movements (Bhatia, 2001; Baik & Lang, 2007). Patients with psychogenic require 
further strength and balance than an indifferent gait and they seem to be frightened of 
falling, and this gait allows them to be closer to the floor (Stone & Carson, 2010). The 
movement disorder is commonly accompanied by other psychogenic neurological 
symptoms, such as false weakness or sensory findings, or by excessive pain and tenderness 
(Thomas & Jankovic, 2004).  Okun et al. described 9 consecutive patients who presented 
with a psychogenic gait disorder who underwent "chair testing." Each patient was asked to 
walk 20-30 feet forward and backward toward the examiner. Patients were then asked to sit 
in a swivel chair with wheels and to propel the chair forward and backward. Compared 
with their walking, 8 of the 9 patients in the psychogenic group performed well on the chair 
test, showing improved ability to propel a chair forward when seated. By contrast, all 9 
control patients with nonpsychogenic gait problems, performed equally when walking or 
propelling utilizing the chair (Okun et al., 2007).  
 
 
Fig. 2. Tightrope walking: the patient walks very slowly on a broad base with his arms 
extended. 
4.1.5 Psychogenic myoclonus 
Myoclonus account for 10% to 20% of PMDs. The clinical features of psychogenic myoclonus 
usually includes segmental or generalizes jerking, occurring at rest and during movement, 
commonly changing pattern, frequency, amplitude and anatomic distribution and may be 
stimulus sensitive (Monday & Jankovic 1993; Williams et al., 1995). 
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Neurophysiologic methods are particularly useful in distinguishing between voluntary 
jerking and cortical or brainstem myoclonus (Brown & Thomson, 2001). Organic myoclonus 
is characterized by burst length of less than 70 ms, and jerks lasting longer than that are 
suggestive of a psychogenic etiology. Functional myoclonus is often associated with a 
Bereitschaftpotential before the movement, which requires recording multiple events using 
an electroencephalogram and back averaging according to an electromyogram. In the 
absence of a Bereitschaftpotential, it is not possible to exclude a psychogenic etiology, as the 
Bereitschaftpotential can be absent in normal subjects (Brown & Thomson, 2001; Peckham & 
Hallett, 2009). Interestingly, in a recent case series of 35 consecutive patients with jerks of the 
trunk referred as possible proriospinal myoclonus, 34 patients showed features suggestive 
of a psychogenic origin even in the presence of a classic polymyography pattern or in the 
absence of a Bereitschaftpotential (van der Salm et al., 2010). 
5. Treatment 
There is no consensus even among the experts about the best treatment approach to patients 
with PMDs. Therefore, a common agreement is that treatment begins when the physician 
has made the diagnosis and mostly depending on the way of explaining PMDs to the 
patient, as well as a very close working relationship between neurologist, consulting 
psychiatrist, and frequently physical therapist, is crucial in obtaining symptom remission in 
many subjects. Table 4 emphasizes, by the acronym form THERAPIST, the essential basis for 
a treatment process. 
 
 
Terminology must engage and not alienate the patient 
 Hear out the patient with interest, compassion, and empathy (and patience) 
  Explain the diagnosis and the mechanism of symptoms 
   Reassure that there is no evidence of neurologic damage  
    Address psychosocial and family issues  
     Prognosis is likely favorable, the patient has the potential to recovery fully 
      Individualize the therapy and customize it 
       Self-help is a crucial part of getting better 
        Treat concurrent psychiatric and medical illness (if present)  
 
Table 4. Nine essential steps for an approach to management of patients with PMDs. 
The objective of effective treatment is not only to provide symptoms remission in the short 
term, but to evaluate the causes that produced the heterogeneous symptomatology and to 
assess feasible strategies to remove them.  
The issue about the terminology to use for the diagnosis is unresolved. Some authors find 
that “functional” disorder is an accurate term, which describe a disorder of the way the 
brain is working. Others find “psychogenic” an acceptable term with vagueness implication. 
Still others think that the latter arouses too much a “crazy” condition in the patient and 
family’s mind and prefer the more broad word “neuropsychiatric” (Williams et al., 2005; 
Stone & Carson, 2010). In any case, whatever term is used it is important to find an 
explanatory language that engages the patient and gives a scenario within which to 
understand the disorder. In this regard, a self-rating approach reported that 49% of patients 
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attributed a favorable outcome to a physician’s described treatment (Jankovic & Thomas, 
2006). 
It is very important to reassure the patient early on, for example emphasizing that this is an 
‘‘involuntary’’ condition and is most likely the result of an impairment of neural pathways. 
Another option is to explain that some of the symptoms are stress-related symptoms, 
pointing out that stress is a common cause of many physical afflictions. A sincere, 
supportive, hopeful and, professional manner of approach will allow to understand and, at 
the same time, have patients understand what the movement disorder means, what is its 
functions, why and when it evolved. Some experts and the authors also suggest an active 
physiotherapy program, from the beginning, in order to desensitized the stress-induced 
contraction that generate the anomalous muscle jerks. Overall, this aspect of the treatment 
may corroborate the “physical” dimension of the disorder and may allow decreasing the 
symptom without activating psychological defence mechanisms (Williams et al., 2006; 
Rosebush & Mazurek, 2006). Besides, the physiotherapist frequently recognizes the fears 
and unhelpful preconceptions which patients have, and can stimulate and compliment 
patients in their activity in a much more confidential mode than the allied psychotherapist.  
Medication treatment can be initiated and the choice of a particular drug depends on the 
accompanying psychiatric or medical conditions. In authors experience these most 
frequently include anxiety, depression, insomnia and headache, and a low dose of tricyclic 
antidepressants or benzodiazepine can help with symptoms of pain and muscle tension.  
Large randomized studies in patients with PMDs are lacking, and evidence for treatment is 
largely based on retrospective, case control, and case report studies. Several other clinical 
trials, not specifically designed for PMDs but for other forms of conversion or somatoform 
disorders, are treated more in detail elsewhere in this book. 
In a study by Voon and co-workers, 23 patients were identified with PMDs, and 15 patients 
agreed to be treated with antidepressant drugs. Of the 15 patients, 10 were diagnosed with 
primary PMDs, and the remaining 5 were diagnosed with PMDs and another somatoform 
disorder. Patients were treated with either citalopram or paroxetine. Those who did not 
respond were switched to venlafaxine. Of the primary PMDs patients, 80% (8 patients) had 
marked improvement, and 7 patients had complete remission. None of the 5 patients with 
PMDs and other somatoform disorders improved. (Voon, & Lang, 2005).  
An open-label trial of somatisation disorder studied the efficacy of nefazodone in patients 
with and without comorbid depression and showed improvement in clinical global 
impression and functioning in 73% of patients (Menza et al., 2001). 
In a study by Rampello and colleagues, 18 patients were treated (6 with haloperidol and 12 
with sulpiride). The latter group showed remarkable improvement in 8 patients, partial 
improvement in 2 patients, and no improvement in 1 patient. The haloperidol group 
showed 1 patient with remarkable improvement, 3 with partial improvement, and 2 with no 
improvement. This study showed a possible positive correlation between dopamine 
blockade, drug-induced plasma prolactine concentration, and improvement in a patient’s 
conversion symptoms.  
Hinson and colleagues recruited ten patients with PMDs for a single-blind clinical trial to 
receive 12 weeks of treatment with outpatient psychodynamic psychotherapy and use of 
antidepressants or anxiolytic drugs, depending on comorbid psychiatric diagnosis. The 
movement disorder was videotaped before and after treatment and rated in a random order 
by a rater unaware of treatment allocation using PMDRS. All patients were diagnosed with 
conversion disorder. Nine of ten recruited patients completed the study. Total mean PMDRS 
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and total mean PMDRS function scores improved with psychotherapeutic intervention. 
There were significant treatment effects in Hamilton depression scores, Beck anxiety scores, 
and global assessment of function. 
Shapiro and Teasell described a case series of 39 consecutive patients with conversion 
disorder who were told that they had a musculoskeletal problem that could resolve 
completely if they had an organic etiology. If the patients did not improve after 4 weeks, 
then  they were told that it was a psychiatric condition, and the treatment would be 
modified to help them improve completely. If they did not improve, then they were given a 
final diagnosis of conversion disorder, and they were told that they could not improve 
because of an unconscious need to remain disabled. In 8 of 9 patients with acute conversion 
disorder (symptoms <2 months), the treatment was successful. In 1 of 28 chronic (>6 months 
duration) patients, behavioral treatment was successful (Shapiro & Teasell, 2004). In a 
randomised controlled clinical trial, Moene and colleagues assigned 48 patients to receive 
either hypnosis or a control intervention consisting of generic elements of psychotherapy. 
Outcome measures were a video rating scale for motor conversion symptoms, the symptom 
checklist-90, and elements of the international classification of impairments, disabilities, and 
handicaps. Independent of the treatment condition, 65% of patients showed substantial 
improvement at post-treatment assessment and 84% at 6-month follow-up, which suggests 
that both psychotherapy and hypnosis have a role in the treatment of conversion disorder.  
A meta-analysis of studies of cognitive behavioral therapy  for various somatisation 
syndromes showed a definite or possible treatment effect of cognitive behavioral therapy in 
71 of patients (Kroenke et al., 2000). Randomized controlled studies support the efficacy of 
individual cognitive behavioral therapy for the treatment of hypochondriasis, body 
dysmorphic disorder, and undifferentiated somatoform disorders including medically 
unexplained symptoms, chronic fatigue syndrome, and noncardiac chest pain (Looper & 
Kirmayer, 2002; Allen et al., 2006). 
In a single-blind study, 16 patients with PMDs completed a thrice-weekly, 12-weeks mild 
walking program. Assessments included DSM-IV interview, PMDRS, Beck Anxiety 
Inventory, Hamilton Depression Scale, V02 Max, and body mass index. A comparison of all 
measures taken at study onset and after completing the exercise program indicates 
statistically significant improvements. We observed a relevant improvement in 10 of 16 
patients (62%). The mean difference for the primary outcome (PMDRS total) corresponded 
to about 70%. Compliance was good, and there were no adverse effects. This study provides 
preliminary evidence for regular low-medium intensity exercise as a safe, adequate, and 
pleasing intervention for PMD. (Dallocchio et al., 2010).  
A retrospective study was performed in 10 patients with psychogenic gait. Patients were 
treated with physical therapy, occupational therapy, and recreational therapy, and 
psychological interventions were used in appropriate cases. All patients were able to 
ambulate normally before discharge (Speed, 1996).  
A successful management of the three cases described in another report involved a 
combination of behavioral modification and physical therapy interventions Abnormal 
movement patterns were ignored, and correct movement patterns were reinforced using 
feedback and praise. All three patients showed complete resolution of their symptoms 
(Ness, 2007). 
There is one published abstract report where EMG biofeedback  as used as a treatment for 
psychogenic tremor; this open label study estimated the effectiveness of biofeedback 
therapy and found improvement in 60% of 15 subjects (Levy et al., 2006). One case report 
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described a dramatic response to acupuncture in a patient with chronic, treatment-resistant 
PMD (Van Nuenen et al. 2007).  
A preliminary experience with the application of transcranial magnetic stimulation to 
achieve symptom relief in psychogenic tremor showed its effectiveness in conversion 
disorder of motor subtype.  In a group of 8 patients, 4 responded, 2 showed temporary 
improvement, and 2 did not respond. (Dafotakis et al., 2008). In  a case report, a patient with 
psychogenic dysphonia was reported to have a dramatic improvement after 2 sessions of 
repetitive transcranial magnetic stimulation over the prefrontal cortex (Chastan et al., 2009). 
6. Prognosis 
The outcome of patients with PMDs is variable, and several elements that influence recovery 
have been described. These include the nature, chronicity, seriousness of the veiled 
psychopathology, the influence of external factors, the attitude of the patient, the capability 
of the patient’s support system, as well as the modalities and the effectiveness of treatment. 
Predominantly, data are available on the outcome of conversion disorders in general. 
Williams et al. found a permanent benefit in 52% of 131 patients, with complete, 
considerable and moderate relief in 25%, 21%, and 8% respectively, after a follow-up of an 
average of 1,8 years. They found that age, gender, intelligence, chronicity of illness, and 
types of symptoms had no influence on the outcome. In another longitudinal study of 228 
patients with PMDs improvement symptoms was noticed in 56% of patients, 21% reported 
no change, and 22% were worse after an average duration of 3.4 years’ follow-up. In this 
study, poor prognostic factors were inconsistent movements, dissatisfaction with the 
physician, long duration of illness, positive history of smoking, and suggestibility. Good 
prognostic factors were good physical health, positive social life, patients’ perception of 
receiving effective treatment by the physician, elimination of a stressor, comorbid diagnosis 
of anxiety, and attribution of a specific medication (Thomas et al., 2006). A follow up report 
compared 66 patients with PMDs to 704 with Parkinson’s disease and showed comparable 
levels of of disability and physical quality of life, increased psychiatric comorbidity and 
more severe mental health disorders, even if patients with PMDs were 20 years younger and 
had a shorter pathological condition (Anderson et al., 2007). 
Feinstein et al. reported persistence of abnormal movements in 90% of 88 patients followed 
up for an average of 3,2 years. Poor outcome was associated with psychiatric, long duration 
of symptoms, and insidious onset of symptoms (Feinstein, (2001). Much higher rates of 
improvement was reported in another longitudinal study of 127 patients with psychogenic 
tremor followed for at least 3 years, 55% reported improvement in tremor. Dissatisfaction 
with the physician was identified as the stronger prognostic risk factor of poor long term 
outcome; good prognostic factors were physician’s prescribed treatment, elimination of 
stressor, specific medication, stress management, biofeedback, and psychotherapy  (Jankovic 
et al., (2004). Other authors described the presenting features and long-term outcomes of 33 
patients with electrophysiologically-confirmed psychogenic tremor by a follow-up 
questionnaire. After a median follow-up of 3.2 years, 64% of patients valued their disability 
as moderate severe, 27% had complete resolution of symptoms, and 9% reported mild 
unchanged symptoms. Of the patients who had resolution of symptoms, in 15% the 
resolution occurred spontaneously and in 12% it occurred after an intervention (1 with an 
antidepressant, 1 with psychology/rehabilitation, 1 with hypnotherapy, 1 with behavioral 
therapy). (McKeon et al., (2008). In a follow study involving 64 patients affected by 
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medically unexplained movement disorders, 28% showed complete resolution of symptoms, 
20% improved, 14% remained unchanged, and 38% worsened after 6 years of follow-up 
(Crimlisk et al., 1998). Finally, other data showed that 83% of 42 patients with functional 
weakness or sensory symptoms, who have been investigated as inpatients, have symptoms 
and disability after a median of 12 years following initial assessment. In this study patients 
with only sensory symptoms and signs at presentation had significantly better outcome in 
terms of higher physical functioning, social functioning , and pain than patients with any 
symptoms or signs of weakness , a higher age of onset predicted lower physical functioning 
at follow up (Stone et al., 2003). If untreated, PMDs are inclined to become chronic, and 
follow-up data in several studies demonstrate 65-95% of patients are left with a high level of 
disability (Factor et al., 1995; Williams et al., 2005), undoubtedly asserting the necessity for 
un effective early intervention to convert the “sick role” of the patient and return to the 
suitable level of function as quickly as possible. 
7. Conclusion  
PMDs are important and underdiagnosed cause of major neurologic disability. Signs and 
symptoms must be interpreted in the overall clinical and psychological context. 
Neurophysiological and imaging findings may provide important understanding and 
confirmation of the diagnosis, but some cases pose a arduous challenge to both neurologists 
and psychiatrists. An adequate explanation of the symptoms to patients is a prerequisite to 
successful further treatment (Stone & Carson, 2010; Friedman & LaFrance, 2010). To date, 
the treatment for each patient with PMDs is individualized and may include 
psychotherapeutic interventions, behavioral therapy, pharmachotherapy, physical therapy, 
hypnosis and others. Recovery is sometimes delayed and can take place over the course of 
months and several patients are left with a high level of disability, but a supportive, 
nonjudgmental, and persistent multidisciplinary approach can divert the illness course to an 
excellent clinical outcome (Rosebush & Mazurek, 2006). Further researches are required, not 
only to improve the understanding and management of these heterogeneous diseases, but 
also for reconsidering conversion disorder terminology and positive rather than negative 
diagnostic criteria. 
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